New York, NY -- (SBWIRE) -- 06/12/2013 -- Growing Stock Report expands its NASDAQ Active Stock Watch List adding Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR) and MannKind Corp. (NASDAQ:MNKD).
Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR) a company that together with its subsidiaries, engages in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States is currently down (-1.19%) on 2,129,057 shares traded. Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR) is currently down (-4.38%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR)
MannKind Corp. (NASDAQ:MNKD) a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States is currently up (+0.78%) on 5,512,853 shares traded after MannKind Announced to Present at Wells Fargo Securities Research & Economics 2013 Healthcare Conference on Tuesday, June 18. MannKind Corp. (NASDAQ:MNKD) is currently up (+372.19%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about MannKind Corp. (NASDAQ:MNKD)
GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.GrowingStockReport.com
Disclosure: GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.
Growing Stock Report
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)